Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “2019-nCoV Pneumonia”

303 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 303 results

Testing effectiveness (Phase 2)Study completedNCT04426695
What this trial is testing

Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19

Who this might be right for
COVID-19
Regeneron Pharmaceuticals 2,252
Testing effectiveness (Phase 2)UnknownNCT05047783
What this trial is testing

Masitinib in Patients With Symptomatic Mild to Moderate COVID-19

Who this might be right for
Covid19SARS-CoV2 InfectionCoronavirus Disease 2019
AB Science 78
Large-scale testing (Phase 3)Study completedNCT05107375
What this trial is testing

Clinical Study of Recombinant Novel Coronavirus（COVID-19） Vaccine (CHO Cell) Combined With Influenza Vaccine

Who this might be right for
Coronavirus Disease 2019
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 299
Early research (Phase 1)Study completedNCT04363346
What this trial is testing

Study of FT516 for the Treatment of COVID-19 in Hospitalized Patients With Hypoxia

Who this might be right for
COVID-19
Masonic Cancer Center, University of Minnesota 5
Early research (Phase 1)Study completedNCT05923424
What this trial is testing

A Trial to Learn if Different Doses of REGN17092 Are Safe in Healthy Adults

Who this might be right for
Healthy Volunteers
Regeneron Pharmaceuticals 40
Not applicableStudy completedNCT04673279
What this trial is testing

Long-term COVID-19 Immune Response in a Vulnerable Neighbourhood in Argentina

Who this might be right for
Coronavirus Disease 2019
Hospital Italiano de Buenos Aires 189
Testing effectiveness (Phase 2)Ended earlyNCT04391309
What this trial is testing

COVID-19 and Anti-CD14 Treatment Trial

Who this might be right for
Coronavirus Disease 2019 (COVID-19)Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
National Institute of Allergy and Infectious Diseases (NIAID) 49
Not applicableUnknownNCT04326387
What this trial is testing

Evaluation of Novel Diagnostic Tests for COVID-19

Who this might be right for
Acute DiseaseCoronavirusRespiratory Viral Infection
CCTU- Cancer Theme 200
Testing effectiveness (Phase 2)Ended earlyNCT04365257
What this trial is testing

Prazosin to Prevent COVID-19 (PREVENT-COVID Trial)

Who this might be right for
COVID-19
Johns Hopkins University 5
Early research (Phase 1)Study completedNCT05339334
What this trial is testing

Learn About the Study Medicine PF-07321332 and Ritonavir in Adult Healthy Chinese Participants.

Who this might be right for
Healthy Participants
Pfizer 14
Not applicableNo Longer AvailableNCT05235347
What this trial is testing

Sotrovimab Expanded Access Treatment Protocol (COVID-19)

Who this might be right for
Covid19
Vir Biotechnology, Inc.
Large-scale testing (Phase 3)UnknownNCT04261270
What this trial is testing

A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia

Who this might be right for
2019-nCoV Pneumonia
Tongji Hospital 60
Not applicableUnknownNCT04747366
What this trial is testing

Analysis of the Pathophysiology and Pathology of Coronavirus Disease 2019 (COVID-19), Including Chronic Morbidity

Who this might be right for
Covid19
Charite University, Berlin, Germany 750
Not applicableStudy completedNCT04588363
What this trial is testing

COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-C

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Multisystem Inflammatory Syndrome in Children (MIS-C)Coronavirus Disease 2019 (COVID-19)
National Institute of Allergy and Infectious Diseases (NIAID) 244
Early research (Phase 1)Study completedNCT04483375
What this trial is testing

Safety, Tolerability and Pharmacokinetics of SCTA01, an Anti-SARS-CoV-2 Monoclonal Antibody, in Healthy Chinese Subjects

Who this might be right for
Coronavirus Disease 2019(COVID-19)
Sinocelltech Ltd. 33
Testing effectiveness (Phase 2)Study completedNCT04414618
What this trial is testing

Opaganib in Coronavirus Disease 2019 Pneumonia

Who this might be right for
Coronavirus Infections
RedHill Biopharma Limited 42
Early research (Phase 1)Ended earlyNCT05487040
What this trial is testing

Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease

Who this might be right for
COVID-19
Pfizer 15
Not applicableLooking for participantsNCT07504341
What this trial is testing

Physiological Finding in Management of COVID 19 Patients

Who this might be right for
COVID-19 (Coronavirus Disease 2019)
St. Martin De Porress Hospital 15,000
Testing effectiveness (Phase 2)Ended earlyNCT04458298
What this trial is testing

Evaluate OP-101 (Dendrimer N-acetyl-cysteine) in Severe Coronavirus Disease 2019 (COVID-19) Patients

Who this might be right for
COVID-19
Ashvattha Therapeutics, Inc. 28
Testing effectiveness (Phase 2)Study completedNCT05567952
What this trial is testing

Learn About a Repeat 5-Day Treatment With the Study Medicines (Called Nirmatrelvir/Ritonavir) in People 12 Years Old or Older With Return of COVID-19 Symptoms and SARS-CoV-2 Positivity After Finishing Treatment With Nirmatrelvir/Ritonavir

Who this might be right for
COVID-19
Pfizer 436
Load More Results